EVE SCHOENEFELD: Open Payments
NPI 1952613317 · GIG HARBOR, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,312 in 77 payments from 10 companies in 2025. Trend: 2023 $395 · 2024 $887 · 2025 $1,312
Food & beverage: $1,212Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $586 |
| Janssen Biotech, Inc. | 17 | $369 |
| Galderma Laboratories, L.P. | 3 | $73 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $53 |
| Arcutis Biotherapeutics, Inc. | 3 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| UCB, Inc. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| LEO Pharma Inc. | 1 | $25 |
Products named: TREMFYA, SKYRIZI, RINVOQ, NEMLUVIO, BOTOX, ILUMYA, Zoryve, DUPIXENT.
Industry payments across WA — which companies pay providers there.
